Maximum Daily Dose of Loperamide (Imodium)
The maximum recommended daily dose of loperamide (Imodium) is 16 mg per day. 1, 2, 3
Dosing Guidelines for Different Conditions
Acute Diarrhea (Adults)
- Initial dose: 4 mg (two capsules) 1
- Followed by: 2 mg (one capsule) after each unformed stool 1
- Maximum daily dose: 16 mg (eight capsules) 1, 2
- Clinical improvement usually occurs within 48 hours 1
Chronic Diarrhea (Adults)
- Initial dose: 4 mg (two capsules) 1
- Followed by: 2 mg (one capsule) after each unformed stool until diarrhea is controlled 1
- Average daily maintenance dosage: 4 to 8 mg (two to four capsules) 1
- Maximum daily dose: 16 mg (eight capsules) 1
- If no improvement after 16 mg/day for 10 days, symptoms are unlikely to be controlled by further administration 1
Special Populations
Elderly Patients
- No dose adjustment required specifically for age 1
- However, elderly patients may be more susceptible to QT interval prolongation 1
- Caution advised in elderly taking medications that can prolong QT interval (e.g., Class IA or III antiarrhythmics) 1
Renal Impairment
- No dosage adjustment required for patients with renal impairment 1
- Metabolites and unchanged drug are mainly excreted in feces 1
Hepatic Impairment
- Use with caution due to potentially increased systemic exposure from reduced metabolism 1
- No specific dosage adjustment guidelines provided 1
Management of Chemotherapy-Related Diarrhea
Uncomplicated Diarrhea
- Initial dose: 4 mg 2
- Followed by: 2 mg every 4 hours or after every unformed stool 2
- Maximum daily dose: 16 mg 2
- Should be accompanied by oral hydration and dietary modifications 2
Complicated Diarrhea
- Same dosing as uncomplicated diarrhea (maximum 16 mg/day) 2
- May require hospitalization, IV fluids, and additional interventions like octreotide 2
Safety Considerations
Cardiac Risk
- High doses of loperamide (much higher than recommended) have been associated with serious cardiac events including QT prolongation, torsades de pointes, and cardiac arrest 4, 5
- However, the incidence of serious cardiac events at recommended doses remains low 5
- The risk of complications from uncontrolled diarrhea likely outweighs the rare cardiac risk associated with therapeutic doses 5
Monitoring
- Patients should receive appropriate fluid and electrolyte replacement as needed 1, 3
- Monitor for signs of dehydration 3
- Pay attention to the risk of paralytic ileus when using high-dose loperamide, especially in stoma patients 3